Wouter Joustra MSc
General Partner
VectivBio AG is a global, clinical-stage biotechnology company developing innovative treatments for severe rare conditions with significant unmet medical need.
VectivBio AG is a global, clinical-stage biotechnology company developing innovative treatments for severe rare conditions with significant unmet medical need.
The company is committed to pursuing severe rare diseases with well-defined biology that can be targeted with therapies that have the potential to meaningfully transform and improve the lives of patients.
Industry
Biotech
Status
Past
Location
Switzerland
Forbion team
Mathias Vinther PhD
Principal